Shoihciro Taniuchi

Dr. Shoihciro Taniuchi

Pediatrics, Takatsuki General Hospital, Takatsuki, Japan
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MTMasaya Takahashi
Masaya Takahashi
KSKazuhiko Soejima
Kazuhiko Soejima
STShoihciro Taniuchi
Shoihciro Taniuchi
YHYasuko Hatano
Yasuko Hatano
SYSohsaku Yamanouchi
Sohsaku Yamanouchi
KKKazunari Kaneko
Kazunari Kaneko
We evaluated the efficacy and safety of oral immunotherapy (OIT) combined with 24 weeks of omalizumab (OMB) at inducing desensitization in children with cow’s milk allergy (CM) compared with an untreated group. The present study was a prospective randomized controlled trial. Sixteen patients (age, 6–14 years) with high IgE levels to CM were enrolled in the present study. Patients were randomized 1:1 to receive OMB-OIT group or untreated group. The primary outcome was the induction of desensitization at 8 weeks after OMB was discontinued in OMB-OIT treated group and at 32 weeks after study entry. None of the 6 children in the untreated group developed desensitization to CM while all of the 10 children in the OIT-OMB treated group achieved desensitization (P < 0.001). A significantly decreased wheal diameter in response to a skin prick test using CM was found in the OMB-OIT treated group (P < 0.05). These data suggest that OIT combined with OMB using microwave heated CM may help to induce desensitization for children with high-risk CM allergy. This prospective randomized controlled trial was intended for 50 participants but was prematurely discontinued due to overwhelming superiority of OMB combined with microwave heated OIT over CM avoidance.

16 June 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
STShoihciro Taniuchi
Shoihciro Taniuchi
RSRika Sakai
Rika Sakai
TNTakahiro Nishida
Takahiro Nishida
MGMeguru Goma
Meguru Goma
MMMasatoshi Mitomori
Masatoshi Mitomori
HKHiroshi Kido
Hiroshi Kido
To increase the prediction accuracy of positive oral food challenge (OFC) outcomes during stepwise slow oral immunotherapy (SS-OIT) in children with a hen’s egg (HE) allergy, we evaluated the predictive value of the combination of antigen-specific IgE (sIgE) with antigen binding avidity and sIgG4 values. Sixty-three children with HE allergy undergoing SS-OIT were subjected to repeated OFCs with HE. We measured the ovomucoid (OVM)-sIgE by ImmunoCAP or densely carboxylated protein (DCP) microarray, sIgG4 by DCP microarray, and the binding avidity of OVM-sIgE defined as the level of 1/IC50 (nM) measured by competitive binding inhibition assays. The OFC was positive in 37 (59%) patients undergoing SS-OIT. Significant differences in DCP-OVM-sIgE, CAP-OVM-sIgE, IC50, DCP-OVM-sIgG4, the multiplication products of DCP-OVM-sIgE, and the binding avidity of DCP-OVM-sIgE (DCP-OVM-sIgE/IC50) and DCP-OVM-sIgE/sIgG4 were compared between the negative and positive groups (p < 0.01). Among them, the variable with the greatest area under the receiver operating characteristic curve was DCP-OVM-sIgE/IC50 (0.84), followed by DCP-OVM-sIgE/sIgG4 (0.81). DCP-OVM-sIgE/IC50 and DCP-OVM-sIgE/sIgG4 are potentially useful markers for the prediction of positive OFCs during HE-SS-OIT and may allow proper evaluation of the current allergic status in the healing process during HE-SS-OIT.

21 August 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MTMasaya Takahashi
Masaya Takahashi
KSKazuhiko Soejima
Kazuhiko Soejima
STShoihciro Taniuchi
Shoihciro Taniuchi
YHYasuko Hatano
Yasuko Hatano
SYSohsaku Yamanouchi
Sohsaku Yamanouchi
KKKazunari Kaneko
Kazunari Kaneko
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

2 December 2025 in Asia Pacific Allergy
Verified
Journal Article
Open access
AIAya Imaide
Aya Imaide
STShoihciro Taniuchi
Shoihciro Taniuchi
SDShuhei Dohi
Shuhei Dohi
MMMasatoshi Mitomori
Masatoshi Mitomori
MGMeguru Gouma
Meguru Gouma
YOYo Okizuka
Yo Okizuka
Non-IgE-mediated gastrointestinal food allergy is a hypersensitivity disorder that affects the gastrointestinal tract, operating independently of IgE. While eosinophilic inflammation has been implicated in the literature, its precise role in the pathophysiology of non-IgE-mediated gastrointestinal food allergy remains poorly understood. We report the first documented case of severe non-IgE-mediated gastrointestinal food allergy in which eosinophil infiltration, eosinophil extracellular traps, and Charcot–Lyden crystals were observed in the tissue. A 1-month-old female infant presented with fever, watery diarrhea, and poor weight gain associated with the ingestion of cow’s milk-based formula. Despite transitioning to an extensively hydrolyzed formula, she developed necrotizing enterocolitis. Following a switch to an amino-acid-based infant formula, her abdominal symptoms resolved, and her weight gain normalized. However, 1 month later, bile-like vomiting led to the diagnosis of jejunal atresia, which was attributed to scarring from necrotizing enterocolitis. Surgical resection revealed histopathological findings of eosinophil infiltration, cytolytic eosinophil cell death (ETosis), extracellular traps, and Charcot–Lyden crystals. The necrotizing enterocolitis was ultimately diagnosed as a severe manifestation of non-IgE-mediated gastrointestinal food allergy triggered by cow’s milk protein. After surgery, the patient resumed feeding with an amino-acid-based infant formula. During regular follow-up, she continued to gain weight well without any clinical symptoms while being fed an amino-acid-based infant formula. To our knowledge, this is the first report to identify a histopathological link between severe non-IgE-mediated gastrointestinal food allergy-related inflammation and eosinophil ETosis. This suggests a potential role of ETosis in the pathogenesis and its complications.


31 May 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
STShoihciro Taniuchi
Shoihciro Taniuchi
RSRika Sakai
Rika Sakai
TNTakashi Nishida
Takashi Nishida
MGMeguru Goma
Meguru Goma
MMMasatoshi Mitomori
Masatoshi Mitomori
HKHiroshi Kido
Hiroshi Kido
To increase the prediction accuracy of positive oral food challenge (OFC) outcome during stepwise slow oral immunotherapy (SS-OIT) in children with hen’s egg (HE) allergy, we evaluated the predictive value of the combination of antigen-specific IgE (sIgE) with antigen binding-avidity and sIgG4 values. Sixty-three children with HE allergy undergoing SS-OIT were subjected to repeated OFC with HE. We measured the ovomucoid (OVM)-sIgE by ImmunoCAP or densely carboxylated protein (DCP) microarray, sIgG4 by DCP microarray, and the binding-avidity of OVM-sIgE defined as the level of 1/ IC50 (nM) measured by competitive binding inhibition assays. The OFC was positive in 37 (59%) patients undergoing SS-OIT. Significant differences in DCP-OVM-sIgE, CAP-OVM-sIgE, I/ IC50, DCP-OVM-sIgG4, the multiplication products of DCP-OVM-sIgE and binding-avidity of DCP-OVM-sIgE (DCP-OVM-sIgE/IC50) and DCP-OVM-sIgE/sIgG4 were compared between the negative and positive groups (p<0.01). Among them, the variable with greatest area under the receiver operating characteristic curve was DCP-OVM-sIgE/IC50 (0.84), followed by DCP-OVM-sIgE/sIgG4 (0.81). DCP-OVM-sIgE/IC50 and DCP-OVM-sIgE/sIgG4 are potentially useful markers for the prediction of positive OFC during HE-SS-OIT and may allow proper evaluation of the current allergic status in the healing process during HE-SS-OIT